| scholarly article | Q13442814 |
| P2093 | author name string | Han J | |
| Kim HS | |||
| Kim J | |||
| Kim K | |||
| Park K | |||
| Jung YS | |||
| Park C | |||
| Kim WS | |||
| Park CH | |||
| Shim YM | |||
| P433 | issue | 1A | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 301-306 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Anticancer Research | Q326290 |
| P1476 | title | Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. | |
| P478 | volume | 19 |
| Q31927242 | Alterations of the transforming growth factor-beta signaling pathway in hepatocellular carcinomas induced endogenously and exogenously in rats |
| Q35594463 | Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression. |
| Q26797238 | Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway |
| Q50087304 | Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer. |
| Q34585219 | Expression and significance of transforming growth factor-β receptor type II and DPC4/Smad4 in non-small cell lung cancer |
| Q58835456 | Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk |
| Q54536639 | Infrequently methylated event at sites -362 to -142 in the promoter of TGF beta R1 gene in non-small cell lung cancer. |
| Q42166815 | Lipid Peroxidation and Transforming Growth Factor-β1 Levels in Gastric Cancer at Pathologic Stages |
| Q34704784 | Mechanisms of oxysterol-induced carcinogenesis. |
| Q35288003 | Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition |
| Q54959883 | Mutations and reduced expression of the transforming growth factor-beta receptor II gene in rat lung adenocarcinomas induced by N-nitrosobis-(2-hydroxypropyl)amine. |
| Q30498249 | Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition |
| Q38856280 | Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition. |
| Q40793851 | Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells |
| Q35653943 | Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signalling |
| Q35009619 | TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth |
| Q35633748 | The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling. |
| Q46816755 | The role of TGF-beta-1 protein and TGF-beta-R-1 receptor in immune escape mechanism in bladder cancer |
| Q37633861 | Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas |
Search more.